Neurophet(380550) said on the 18th it will expand a service that checks brain health with artificial intelligence (AI). Neurophet signed a business agreement with the healthcare company Neomark for this.
The two companies plan to develop a joint business so Neurophet Aqua can be used in corporations' health checkups. Neurophet Aqua analyzes patients' brain nerve images to help determine whether there is a degenerative brain disease.
Neomark operates a corporations and individual health checkup platform. It provides Digital Healthcare services for health management. Han Jae-ung, Neomark's CEO, said, "We will improve the quality of health checkups."
Bin Jun-gil, Neurophet's co-CEO, said, "We will create new value through AI brain image analysis."